The Council of State Bioscience Associations (CSBA) today, released data analyzing the potential impact of various drug pricing proposals on patient access to lifesaving medicines, future biomedical innovation, and the economic health of the life sciences industry. 

The study, which was conducted by Vital Transformation, an international health economics firm, examines the negative effects of bills like “Lower Drug Costs Now Act of 2019” and other foreign reference pricing models had they been enacted. 

Continue reading→

Arizonans age 16 and up can be vaccinated at state sites

PHOENIX — Registration at Arizona’s state-operated COVID-19 vaccination sites in Maricopa, Pima and Yuma counties will be open to all Arizonans 16 and older beginning at 8 a.m. Wednesday, March 24, Governor Doug Ducey and the Arizona Department of Health Services announced today.

Continue reading→

TUCSON, Ariz. – SGNT, a University of Arizona Center for Innovation (UACI) startup, has received a $749,000 Small Business Innovation Research (SBIR) grant through the National Science Foundation (NSF).  NSF’s vital support of basic research enables people to create knowledge that transforms the future. 

Continue reading→

Joseph Scheeren departing the organization after two years of strong leadership

TUCSON, Ariz., March 19, 2021 — Critical Path Institute (C-Path) today announced that its Chief Operating Officer Kristen Swingle, M.S., has been appointed Interim President, effective immediately. Kristen succeeds Joseph Scheeren, Pharm.D., C-Path’s President and Chief Executive Officer since April 2019. Scheeren cited personal reasons for stepping down after stewarding C-Path through an important time of transformation, which has seen the organization add multiple new programs and its staff more than double.Continue reading→

Company’s first prototype product—a lightweight, wearable robotic ankle assist device—is designed to grow with the patient, an innovation that meets a specific market needContinue reading→

PHOENIX, March 18, 2021 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the conclusion of agricultural deployments of ContraPest® with demonstrated, sustained success in reducing rat populations and improving operating economies in poultry settings.Continue reading→

• Multiplexed assays for simultaneously detecting several biomarkers in a single sample address the growing need to obtain more information from limited tissue samples
• New test kit is an addition to line of DISCOVERY ULTRA instruments, uniquely designed for the research community
• Researchers can now investigate more cancer biomarkers on a single tissue slide, paving the way for a better understanding of cancer biology and future advances in personalised healthcare

Continue reading→